
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AI and ML-based risk assessment of chemicals: predicting carcinogenic risk from chemical-induced genomic instability
Ajay Vikram Singh, Preeti Bhardwaj, Peter Laux, et al.
Frontiers in Toxicology (2024) Vol. 6
Open Access | Times Cited: 12
Ajay Vikram Singh, Preeti Bhardwaj, Peter Laux, et al.
Frontiers in Toxicology (2024) Vol. 6
Open Access | Times Cited: 12
Showing 12 citing articles:
Food Recommendation Towards Personalized Wellbeing
Guanhua Qiao, Dachuan Zhang, Nana Zhang, et al.
Trends in Food Science & Technology (2025), pp. 104877-104877
Closed Access | Times Cited: 1
Guanhua Qiao, Dachuan Zhang, Nana Zhang, et al.
Trends in Food Science & Technology (2025), pp. 104877-104877
Closed Access | Times Cited: 1
Large Language Models as Tools for Molecular Toxicity Prediction: AI Insights into Cardiotoxicity
Hengzheng Yang, Jian Xiu, W. C. Yan, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access | Times Cited: 1
Hengzheng Yang, Jian Xiu, W. C. Yan, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access | Times Cited: 1
Inhibitory potential of Polyphenolic Stilbene derivatives with Glycogen Synthase Kinase-3β (GSK-3β) for Alzheimer's disease: Computational and SAR Insights
Santosh Prasad Chaudhary Kurmi, Dipanjan Karati
Brain Disorders (2025), pp. 100182-100182
Open Access
Santosh Prasad Chaudhary Kurmi, Dipanjan Karati
Brain Disorders (2025), pp. 100182-100182
Open Access
Descriptors Divide‐and‐Conquer Enables Multifaceted and Interpretable Materials Structure–Activity Relationship Analysis
Yue Liu, Linhan Wu, Zhengwei Yang, et al.
Advanced Functional Materials (2025)
Closed Access
Yue Liu, Linhan Wu, Zhengwei Yang, et al.
Advanced Functional Materials (2025)
Closed Access
Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access
Influence of experimental variables on spheroid attributes
Songshan Zhu, Jun Yin, Xiaotong Lu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Songshan Zhu, Jun Yin, Xiaotong Lu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An interpreting machine learning models to predict amputation risk in patients with diabetic foot ulcers: a multi-center study
Haoran Tao, Lili You, Yuhan Huang, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Haoran Tao, Lili You, Yuhan Huang, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Machine learning applications in risk management: Trends and research agenda
Alejandro Valencia-Arías, Jesús Alberto Jiménez García, Erica Agudelo-Ceballos, et al.
F1000Research (2025) Vol. 14, pp. 233-233
Open Access
Alejandro Valencia-Arías, Jesús Alberto Jiménez García, Erica Agudelo-Ceballos, et al.
F1000Research (2025) Vol. 14, pp. 233-233
Open Access
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Predicting biomolecule adsorption on nanomaterials: a hybrid framework of molecular simulations and machine learning
Ewelina Wyrzykowska, Mateusz Balicki, Iwona Anusiewicz, et al.
Nanoscale (2025)
Closed Access
Ewelina Wyrzykowska, Mateusz Balicki, Iwona Anusiewicz, et al.
Nanoscale (2025)
Closed Access
Does use of generative AI chatbots by patients introduce risk of adverse drug events?
Roger S. McIntyre
Expert Opinion on Drug Safety (2025)
Closed Access
Roger S. McIntyre
Expert Opinion on Drug Safety (2025)
Closed Access
Innovative nanoparticle strategies for treating oral cancers
Shahryar Irannejadrankouhi, Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Shahryar Irannejadrankouhi, Hassan Mivehchi, Aisan Eskandari-Yaghbastlo, et al.
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access